World Hepatitis Day and the role of clinical research Hepatitis is an inflammation of the liver, most commonly caused by viral infection. One of the world’s leading causes of death, viral hepatitis kills as many people worldwide as HIV/AIDS, malaria or tuberculosis. In 2019, WHO estimated that hepatitis B and C caused the deaths of 1.3 million people. Ahead of World Hepatitis Day on July 28,
Cromos Pharma highlights Sarcoma Awareness Month This July, Cromos Pharma is highlighting Sarcoma Awareness Month. What are sarcomas? Sarcomas are rare malignant (cancer) tumors that start in the bones and soft tissues. The most common type of sarcoma is soft tissue sarcoma. Four out of five sarcomas occur in soft issues. Over half of these are found in the leg but
Cromos Pharma on the advantages of conducting clinical trials in Poland Cromos Pharma has been successfully delivering full service clinical research solutions in Poland since 2015. Poland is one of our key locations across Central and Eastern Europe for carrying out clinical trials. Our team has specialist knowledge of the country and the wider region to ensure rapid patient recruitment, expedited study timelines and high quality
